De novo Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions
Authors:
Open Access
- 28 September 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
Cardiovascular disease (CVD) is the leading cause of mortality, resulting in approximately one-third of deaths worldwide. Among CVD, acute myocardial infarctions (MI) is the leading cause of death. Current treatment modalities for treating CVD have improved over the years, but the demand for new and innovative therapies has been on the rise. The field of nanomedicine and nanotechnology has opened a new paradigm for treating damaged hearts by providing improved drug delivery methods, specifically targeting injured areas of the myocardium. With the advent of innovative biomaterials, newer therapeutics such as growth factors, stem cells, and exosomes have been successfully delivered to the injured myocardial tissue, promoting improvement in cardiac function. This review focuses on three major drug delivery modalities: nanoparticles, microspheres, and hydrogels, and their potential for treating damaged hearts following an MI.Keywords
This publication has 112 references indexed in Scilit:
- Controlled Delivery of Sonic Hedgehog Morphogen and Its Potential for Cardiac RepairPLOS ONE, 2013
- The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injuryBiomaterials, 2010
- Effect of Homogenization Techniques on Reducing the Size of Microcapsules and the Survival of Probiotic Bacteria ThereinJournal of Food Science, 2009
- Optimization of Fabrication Parameters To Produce Chitosan−Tripolyphosphate Nanoparticles for Delivery of Tea CatechinsJournal of Agricultural and Food Chemistry, 2008
- Engineering Biodegradable Polyester Particles With Specific Drug Targeting and Drug Release PropertiesJournal of Pharmaceutical Sciences, 2008
- Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequencesNature Protocols, 2007
- Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheresBioMagnetic Research and Technology, 2007
- Synthesis and Characterization of PEG Dimethacrylates and Their HydrogelsBiomacromolecules, 2004
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002
- The Role of Growth Factors in Wound HealingThe Journal of Trauma: Injury, Infection, and Critical Care, 1996